Key Insights
The global breast biopsy market, currently valued at approximately $0.41 billion in 2025, is projected to experience robust growth, exhibiting a Compound Annual Growth Rate (CAGR) of 21.23% from 2025 to 2033. This significant expansion is driven by several key factors. Rising breast cancer incidence rates worldwide, coupled with advancements in biopsy techniques leading to earlier and more accurate diagnoses, are major contributors. The increasing adoption of minimally invasive procedures like image-guided biopsies (stereotactic, ultrasound, MRI-guided) reduces patient discomfort and recovery time, fueling market growth. Furthermore, technological innovations such as molecular diagnostics integrated with biopsies provide valuable prognostic and predictive information, influencing treatment decisions and enhancing patient outcomes. The market is segmented by circulating biomarkers, including circulating tumor cells (CTCs), circulating cell-free DNA (cfDNA), extracellular vesicles, and others, each contributing to the overall market expansion based on their diagnostic capabilities. The increasing demand for personalized medicine is also driving innovation within the field, leading to the development of more sophisticated biopsy technologies.
The market's geographical distribution reflects global cancer prevalence patterns. North America currently holds a significant market share due to advanced healthcare infrastructure and high adoption of advanced diagnostic techniques. However, Asia Pacific is poised for substantial growth, driven by rising healthcare spending and increasing awareness of breast cancer screening and early detection. Europe also represents a significant market with established healthcare systems and ongoing investments in cancer research. Competition in the market is intense, with key players like Fluxion Biosciences Inc, Guardant Health Inc, Bio-Rad Laboratories Inc, and others continually innovating and expanding their product portfolios. The ongoing research and development efforts focused on improving biopsy accuracy, minimizing invasiveness, and integrating advanced molecular diagnostics will continue to shape the market's trajectory over the forecast period.

Breast Biopsy Market: A Comprehensive Report (2019-2033)
This comprehensive report provides an in-depth analysis of the Breast Biopsy Market, offering invaluable insights for industry stakeholders, investors, and researchers. Covering the period from 2019 to 2033, with a base year of 2025 and a forecast period of 2025-2033, this report meticulously examines market dynamics, segmentation, key players, and future growth potential. The report leverages robust data analysis and expert insights to provide actionable intelligence for strategic decision-making.
Breast Biopsy Market Concentration & Innovation
The Breast Biopsy Market exhibits a moderately concentrated landscape, with a few major players holding significant market share. The market share distribution among the top five companies – estimated at xx% in 2025 – is driven by factors including technological advancements, robust R&D investments, and strategic acquisitions. Innovation is a key driver, fueled by the continuous development of minimally invasive techniques, advanced imaging technologies, and molecular diagnostic tools that improve diagnostic accuracy and patient outcomes. Regulatory frameworks, such as those set by the FDA, significantly influence market growth, requiring rigorous testing and approvals for new technologies. The market sees ongoing competition from substitute technologies, including less invasive alternatives and improved imaging modalities. End-user trends are shifting toward personalized medicine and improved patient experience, demanding faster, more precise, and less invasive biopsy procedures. M&A activity is prevalent, with significant deals valued at an estimated xx Million in the historical period (2019-2024). For example, the merger between [Insert Example if available, otherwise state "a significant merger within the field"] in [Year] resulted in [Positive outcome, e.g., increased market share and R&D capabilities].
Breast Biopsy Market Industry Trends & Insights
The Breast Biopsy Market is experiencing robust growth, projected to reach xx Million by 2033, with a CAGR of xx% during the forecast period (2025-2033). Several factors contribute to this expansion. Technological disruptions, such as the adoption of image-guided biopsy systems and liquid biopsies, are increasing the precision and accessibility of breast biopsy procedures. Consumer preferences are shifting towards minimally invasive techniques due to reduced pain, shorter recovery times, and improved cosmetic outcomes. Competitive dynamics are shaping the market, with established players investing heavily in R&D to develop innovative products and services, while new entrants bring fresh technological approaches. Market penetration of advanced technologies is steadily increasing, especially in developed regions with advanced healthcare infrastructure and high disposable incomes. The increasing prevalence of breast cancer globally is also a significant growth driver.

Dominant Markets & Segments in Breast Biopsy Market
The North American region currently dominates the Breast Biopsy Market, driven by factors such as high healthcare expenditure, advanced healthcare infrastructure, and a high prevalence of breast cancer. Within the circulating biomarkers segment, Circulating Tumor Cells (CTCs) and Circulating Cell-free DNA (cfDNA) are the leading segments, exhibiting substantial growth prospects.
- Key Drivers for North America:
- High healthcare expenditure and insurance coverage
- Advanced medical infrastructure and skilled professionals
- High incidence of breast cancer
- Early adoption of new technologies
- Stringent regulatory frameworks that support innovation.
The dominance of North America is expected to continue throughout the forecast period, although other regions, particularly Europe and Asia-Pacific, are expected to witness significant growth, driven by factors such as rising healthcare spending, increasing awareness of breast cancer, and government initiatives to improve healthcare access.
Breast Biopsy Market Product Developments
The Breast Biopsy Market witnesses continuous product innovation, with a focus on developing minimally invasive biopsy techniques, advanced imaging systems, and molecular diagnostic tools. This includes enhancements in vacuum-assisted biopsy devices, stereotactic biopsy systems, and the integration of artificial intelligence for image analysis. These innovations improve accuracy, reduce complications, and enhance patient experience. The market increasingly integrates liquid biopsy technology, utilizing circulating biomarkers like CTCs and cfDNA to provide non-invasive diagnostic options. This trend is driven by technological advances in biomarker detection and analysis, offering significant competitive advantages to companies with superior technologies.
Report Scope & Segmentation Analysis
This report segments the Breast Biopsy Market comprehensively, primarily by type of circulating biomarker:
Circulating Tumor Cells (CTCs): This segment is experiencing significant growth due to its potential for early cancer detection and personalized treatment strategies. Market size is projected at xx Million in 2025, with a projected growth of xx% during the forecast period. Competitive dynamics are intense, with several companies focusing on developing advanced CTC enrichment and analysis techniques.
Circulating Cell-free DNA (cfDNA): This segment offers a less invasive alternative to traditional biopsies. Its market size in 2025 is estimated at xx Million, with anticipated growth driven by increasing technological advancements in cfDNA analysis. The competitive landscape is similar to CTCs, with ongoing innovation and several companies competing in this arena.
Extracellular Vesicles: This segment is emerging rapidly, with significant potential for early cancer detection and monitoring. The market is still relatively nascent but demonstrates substantial potential for future growth.
Other Circulating Biomarkers: This segment includes various other biomarkers under research and development, potentially expanding the market's scope further.
Key Drivers of Breast Biopsy Market Growth
The growth of the Breast Biopsy Market is fueled by several factors. Technological advancements, such as minimally invasive techniques and advanced imaging, play a major role. The increasing prevalence of breast cancer globally necessitates reliable and efficient diagnostic tools. Government initiatives to improve healthcare infrastructure and expand access to healthcare services further contribute to market growth. The rising adoption of personalized medicine, which relies heavily on accurate biopsies for targeted treatment, also contributes significantly.
Challenges in the Breast Biopsy Market Sector
The Breast Biopsy Market faces several challenges. High costs associated with advanced technologies can limit accessibility, particularly in resource-constrained settings. Stringent regulatory requirements and lengthy approval processes can delay product launches and market entry for innovative technologies. Competition from established players and emerging technologies makes the market fiercely competitive. Supply chain disruptions related to raw materials and components can also impact market stability.
Emerging Opportunities in Breast Biopsy Market
Significant opportunities exist within the Breast Biopsy Market. The development and adoption of liquid biopsy technologies offers a non-invasive alternative to traditional biopsies, driving substantial market expansion. Artificial intelligence and machine learning applications show promise in improving image analysis and biomarker detection, enhancing diagnostic accuracy. Growing research into new biomarkers can expand diagnostic options and personalize treatment plans. Expansion into emerging markets with growing healthcare infrastructure presents considerable growth potential.
Leading Players in the Breast Biopsy Market
- Fluxion Biosciences Inc
- Janssen Diagnostics
- Guardant Health Inc
- Bio-Rad Laboratories Inc
- Adaptive Biotechnologies
- F Hoffmann-La Roche Ltd
- Epic Sciences
- PapGene
- Qiagen
- Pathway Genomics (OME Care)
- Exosome Diagnostics Inc
- Illumina Inc
- Myriad Genetics
- Biocept Inc
- Biodesix
Key Developments in Breast Biopsy Market Industry
- [Month, Year]: Company X launched a new image-guided biopsy system, enhancing diagnostic accuracy.
- [Month, Year]: Company Y acquired Company Z, expanding its product portfolio and market presence.
- [Month, Year]: Regulatory approval granted for a novel liquid biopsy technology, opening new market opportunities.
- [Add more bullet points with specific dates and developments as available]
Strategic Outlook for Breast Biopsy Market
The Breast Biopsy Market is poised for continued growth, driven by technological advancements, increasing breast cancer prevalence, and the rising adoption of personalized medicine. Strategic investments in R&D, particularly in liquid biopsy technologies and AI-driven diagnostics, will be crucial for companies to maintain a competitive edge. Expansion into emerging markets and strategic partnerships will offer opportunities for growth. The focus on minimally invasive procedures and improved patient outcomes will remain a key driver of market dynamics.
Breast Biopsy Market Segmentation
-
1. Circulating Biomarkers
- 1.1. Circulating Tumor Cells (CTCs)
- 1.2. Circulating Cell-free DNA (cfDNA)
- 1.3. Extracellular Vesicles
- 1.4. Other Circulating Biomarkers
Breast Biopsy Market Segmentation By Geography
-
1. North America
- 1.1. United States
- 1.2. Canada
- 1.3. Mexico
-
2. Europe
- 2.1. Germany
- 2.2. United Kingdom
- 2.3. France
- 2.4. Italy
- 2.5. Spain
- 2.6. Rest of Europe
-
3. Asia Pacific
- 3.1. China
- 3.2. Japan
- 3.3. India
- 3.4. Australia
- 3.5. South Korea
- 3.6. Rest of Asia Pacific
-
4. Middle East and Africa
- 4.1. GCC
- 4.2. South Africa
- 4.3. Rest of Middle East and Africa
-
5. South America
- 5.1. Brazil
- 5.2. Argentina
- 5.3. Rest of South America

Breast Biopsy Market REPORT HIGHLIGHTS
Aspects | Details |
---|---|
Study Period | 2019-2033 |
Base Year | 2024 |
Estimated Year | 2025 |
Forecast Period | 2025-2033 |
Historical Period | 2019-2024 |
Growth Rate | CAGR of 21.23% from 2019-2033 |
Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Rising Prevalence of Breast Cancer; Increasing Demand for Better Minimally Invasive Therapies; Technological Advancements in the Early Stage Detection of Breast Cancer
- 3.3. Market Restrains
- 3.3.1. Stringent Regulatory Issues; Poor Reimbursement Policies
- 3.4. Market Trends
- 3.4.1. The Circulating Cell-free DNA (cfDNA) Segment is Expected to Hold a Major Market Share
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Global Breast Biopsy Market Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Circulating Biomarkers
- 5.1.1. Circulating Tumor Cells (CTCs)
- 5.1.2. Circulating Cell-free DNA (cfDNA)
- 5.1.3. Extracellular Vesicles
- 5.1.4. Other Circulating Biomarkers
- 5.2. Market Analysis, Insights and Forecast - by Region
- 5.2.1. North America
- 5.2.2. Europe
- 5.2.3. Asia Pacific
- 5.2.4. Middle East and Africa
- 5.2.5. South America
- 5.1. Market Analysis, Insights and Forecast - by Circulating Biomarkers
- 6. North America Breast Biopsy Market Analysis, Insights and Forecast, 2019-2031
- 6.1. Market Analysis, Insights and Forecast - by Circulating Biomarkers
- 6.1.1. Circulating Tumor Cells (CTCs)
- 6.1.2. Circulating Cell-free DNA (cfDNA)
- 6.1.3. Extracellular Vesicles
- 6.1.4. Other Circulating Biomarkers
- 6.1. Market Analysis, Insights and Forecast - by Circulating Biomarkers
- 7. Europe Breast Biopsy Market Analysis, Insights and Forecast, 2019-2031
- 7.1. Market Analysis, Insights and Forecast - by Circulating Biomarkers
- 7.1.1. Circulating Tumor Cells (CTCs)
- 7.1.2. Circulating Cell-free DNA (cfDNA)
- 7.1.3. Extracellular Vesicles
- 7.1.4. Other Circulating Biomarkers
- 7.1. Market Analysis, Insights and Forecast - by Circulating Biomarkers
- 8. Asia Pacific Breast Biopsy Market Analysis, Insights and Forecast, 2019-2031
- 8.1. Market Analysis, Insights and Forecast - by Circulating Biomarkers
- 8.1.1. Circulating Tumor Cells (CTCs)
- 8.1.2. Circulating Cell-free DNA (cfDNA)
- 8.1.3. Extracellular Vesicles
- 8.1.4. Other Circulating Biomarkers
- 8.1. Market Analysis, Insights and Forecast - by Circulating Biomarkers
- 9. Middle East and Africa Breast Biopsy Market Analysis, Insights and Forecast, 2019-2031
- 9.1. Market Analysis, Insights and Forecast - by Circulating Biomarkers
- 9.1.1. Circulating Tumor Cells (CTCs)
- 9.1.2. Circulating Cell-free DNA (cfDNA)
- 9.1.3. Extracellular Vesicles
- 9.1.4. Other Circulating Biomarkers
- 9.1. Market Analysis, Insights and Forecast - by Circulating Biomarkers
- 10. South America Breast Biopsy Market Analysis, Insights and Forecast, 2019-2031
- 10.1. Market Analysis, Insights and Forecast - by Circulating Biomarkers
- 10.1.1. Circulating Tumor Cells (CTCs)
- 10.1.2. Circulating Cell-free DNA (cfDNA)
- 10.1.3. Extracellular Vesicles
- 10.1.4. Other Circulating Biomarkers
- 10.1. Market Analysis, Insights and Forecast - by Circulating Biomarkers
- 11. North America Breast Biopsy Market Analysis, Insights and Forecast, 2019-2031
- 11.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 11.1.1 United States
- 11.1.2 Canada
- 11.1.3 Mexico
- 12. Europe Breast Biopsy Market Analysis, Insights and Forecast, 2019-2031
- 12.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 12.1.1 Germany
- 12.1.2 United Kingdom
- 12.1.3 France
- 12.1.4 Italy
- 12.1.5 Spain
- 12.1.6 Rest of Europe
- 13. Asia Pacific Breast Biopsy Market Analysis, Insights and Forecast, 2019-2031
- 13.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 13.1.1 China
- 13.1.2 Japan
- 13.1.3 India
- 13.1.4 Australia
- 13.1.5 South Korea
- 13.1.6 Rest of Asia Pacific
- 14. Middle East and Africa Breast Biopsy Market Analysis, Insights and Forecast, 2019-2031
- 14.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 14.1.1 GCC
- 14.1.2 South Africa
- 14.1.3 Rest of Middle East and Africa
- 15. South America Breast Biopsy Market Analysis, Insights and Forecast, 2019-2031
- 15.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 15.1.1 Brazil
- 15.1.2 Argentina
- 15.1.3 Rest of South America
- 16. Competitive Analysis
- 16.1. Global Market Share Analysis 2024
- 16.2. Company Profiles
- 16.2.1 Fluxion Biosciences Inc
- 16.2.1.1. Overview
- 16.2.1.2. Products
- 16.2.1.3. SWOT Analysis
- 16.2.1.4. Recent Developments
- 16.2.1.5. Financials (Based on Availability)
- 16.2.2 Janssen Diagnostics
- 16.2.2.1. Overview
- 16.2.2.2. Products
- 16.2.2.3. SWOT Analysis
- 16.2.2.4. Recent Developments
- 16.2.2.5. Financials (Based on Availability)
- 16.2.3 Guardant Health Inc
- 16.2.3.1. Overview
- 16.2.3.2. Products
- 16.2.3.3. SWOT Analysis
- 16.2.3.4. Recent Developments
- 16.2.3.5. Financials (Based on Availability)
- 16.2.4 Bio-Rad Laboratories Inc
- 16.2.4.1. Overview
- 16.2.4.2. Products
- 16.2.4.3. SWOT Analysis
- 16.2.4.4. Recent Developments
- 16.2.4.5. Financials (Based on Availability)
- 16.2.5 Adaptive Biotechnologies
- 16.2.5.1. Overview
- 16.2.5.2. Products
- 16.2.5.3. SWOT Analysis
- 16.2.5.4. Recent Developments
- 16.2.5.5. Financials (Based on Availability)
- 16.2.6 F Hoffmann-La Roche Ltd
- 16.2.6.1. Overview
- 16.2.6.2. Products
- 16.2.6.3. SWOT Analysis
- 16.2.6.4. Recent Developments
- 16.2.6.5. Financials (Based on Availability)
- 16.2.7 Epic Sciences
- 16.2.7.1. Overview
- 16.2.7.2. Products
- 16.2.7.3. SWOT Analysis
- 16.2.7.4. Recent Developments
- 16.2.7.5. Financials (Based on Availability)
- 16.2.8 PapGene
- 16.2.8.1. Overview
- 16.2.8.2. Products
- 16.2.8.3. SWOT Analysis
- 16.2.8.4. Recent Developments
- 16.2.8.5. Financials (Based on Availability)
- 16.2.9 Qiagen
- 16.2.9.1. Overview
- 16.2.9.2. Products
- 16.2.9.3. SWOT Analysis
- 16.2.9.4. Recent Developments
- 16.2.9.5. Financials (Based on Availability)
- 16.2.10 Pathway Genomics (OME Care)
- 16.2.10.1. Overview
- 16.2.10.2. Products
- 16.2.10.3. SWOT Analysis
- 16.2.10.4. Recent Developments
- 16.2.10.5. Financials (Based on Availability)
- 16.2.11 Exosome Diagnostics Inc
- 16.2.11.1. Overview
- 16.2.11.2. Products
- 16.2.11.3. SWOT Analysis
- 16.2.11.4. Recent Developments
- 16.2.11.5. Financials (Based on Availability)
- 16.2.12 Illumina Inc
- 16.2.12.1. Overview
- 16.2.12.2. Products
- 16.2.12.3. SWOT Analysis
- 16.2.12.4. Recent Developments
- 16.2.12.5. Financials (Based on Availability)
- 16.2.13 Myriad Genetics
- 16.2.13.1. Overview
- 16.2.13.2. Products
- 16.2.13.3. SWOT Analysis
- 16.2.13.4. Recent Developments
- 16.2.13.5. Financials (Based on Availability)
- 16.2.14 Biocept Inc
- 16.2.14.1. Overview
- 16.2.14.2. Products
- 16.2.14.3. SWOT Analysis
- 16.2.14.4. Recent Developments
- 16.2.14.5. Financials (Based on Availability)
- 16.2.15 Biodesix
- 16.2.15.1. Overview
- 16.2.15.2. Products
- 16.2.15.3. SWOT Analysis
- 16.2.15.4. Recent Developments
- 16.2.15.5. Financials (Based on Availability)
- 16.2.1 Fluxion Biosciences Inc
List of Figures
- Figure 1: Global Breast Biopsy Market Revenue Breakdown (Million, %) by Region 2024 & 2032
- Figure 2: Global Breast Biopsy Market Volume Breakdown (K Unit, %) by Region 2024 & 2032
- Figure 3: North America Breast Biopsy Market Revenue (Million), by Country 2024 & 2032
- Figure 4: North America Breast Biopsy Market Volume (K Unit), by Country 2024 & 2032
- Figure 5: North America Breast Biopsy Market Revenue Share (%), by Country 2024 & 2032
- Figure 6: North America Breast Biopsy Market Volume Share (%), by Country 2024 & 2032
- Figure 7: Europe Breast Biopsy Market Revenue (Million), by Country 2024 & 2032
- Figure 8: Europe Breast Biopsy Market Volume (K Unit), by Country 2024 & 2032
- Figure 9: Europe Breast Biopsy Market Revenue Share (%), by Country 2024 & 2032
- Figure 10: Europe Breast Biopsy Market Volume Share (%), by Country 2024 & 2032
- Figure 11: Asia Pacific Breast Biopsy Market Revenue (Million), by Country 2024 & 2032
- Figure 12: Asia Pacific Breast Biopsy Market Volume (K Unit), by Country 2024 & 2032
- Figure 13: Asia Pacific Breast Biopsy Market Revenue Share (%), by Country 2024 & 2032
- Figure 14: Asia Pacific Breast Biopsy Market Volume Share (%), by Country 2024 & 2032
- Figure 15: Middle East and Africa Breast Biopsy Market Revenue (Million), by Country 2024 & 2032
- Figure 16: Middle East and Africa Breast Biopsy Market Volume (K Unit), by Country 2024 & 2032
- Figure 17: Middle East and Africa Breast Biopsy Market Revenue Share (%), by Country 2024 & 2032
- Figure 18: Middle East and Africa Breast Biopsy Market Volume Share (%), by Country 2024 & 2032
- Figure 19: South America Breast Biopsy Market Revenue (Million), by Country 2024 & 2032
- Figure 20: South America Breast Biopsy Market Volume (K Unit), by Country 2024 & 2032
- Figure 21: South America Breast Biopsy Market Revenue Share (%), by Country 2024 & 2032
- Figure 22: South America Breast Biopsy Market Volume Share (%), by Country 2024 & 2032
- Figure 23: North America Breast Biopsy Market Revenue (Million), by Circulating Biomarkers 2024 & 2032
- Figure 24: North America Breast Biopsy Market Volume (K Unit), by Circulating Biomarkers 2024 & 2032
- Figure 25: North America Breast Biopsy Market Revenue Share (%), by Circulating Biomarkers 2024 & 2032
- Figure 26: North America Breast Biopsy Market Volume Share (%), by Circulating Biomarkers 2024 & 2032
- Figure 27: North America Breast Biopsy Market Revenue (Million), by Country 2024 & 2032
- Figure 28: North America Breast Biopsy Market Volume (K Unit), by Country 2024 & 2032
- Figure 29: North America Breast Biopsy Market Revenue Share (%), by Country 2024 & 2032
- Figure 30: North America Breast Biopsy Market Volume Share (%), by Country 2024 & 2032
- Figure 31: Europe Breast Biopsy Market Revenue (Million), by Circulating Biomarkers 2024 & 2032
- Figure 32: Europe Breast Biopsy Market Volume (K Unit), by Circulating Biomarkers 2024 & 2032
- Figure 33: Europe Breast Biopsy Market Revenue Share (%), by Circulating Biomarkers 2024 & 2032
- Figure 34: Europe Breast Biopsy Market Volume Share (%), by Circulating Biomarkers 2024 & 2032
- Figure 35: Europe Breast Biopsy Market Revenue (Million), by Country 2024 & 2032
- Figure 36: Europe Breast Biopsy Market Volume (K Unit), by Country 2024 & 2032
- Figure 37: Europe Breast Biopsy Market Revenue Share (%), by Country 2024 & 2032
- Figure 38: Europe Breast Biopsy Market Volume Share (%), by Country 2024 & 2032
- Figure 39: Asia Pacific Breast Biopsy Market Revenue (Million), by Circulating Biomarkers 2024 & 2032
- Figure 40: Asia Pacific Breast Biopsy Market Volume (K Unit), by Circulating Biomarkers 2024 & 2032
- Figure 41: Asia Pacific Breast Biopsy Market Revenue Share (%), by Circulating Biomarkers 2024 & 2032
- Figure 42: Asia Pacific Breast Biopsy Market Volume Share (%), by Circulating Biomarkers 2024 & 2032
- Figure 43: Asia Pacific Breast Biopsy Market Revenue (Million), by Country 2024 & 2032
- Figure 44: Asia Pacific Breast Biopsy Market Volume (K Unit), by Country 2024 & 2032
- Figure 45: Asia Pacific Breast Biopsy Market Revenue Share (%), by Country 2024 & 2032
- Figure 46: Asia Pacific Breast Biopsy Market Volume Share (%), by Country 2024 & 2032
- Figure 47: Middle East and Africa Breast Biopsy Market Revenue (Million), by Circulating Biomarkers 2024 & 2032
- Figure 48: Middle East and Africa Breast Biopsy Market Volume (K Unit), by Circulating Biomarkers 2024 & 2032
- Figure 49: Middle East and Africa Breast Biopsy Market Revenue Share (%), by Circulating Biomarkers 2024 & 2032
- Figure 50: Middle East and Africa Breast Biopsy Market Volume Share (%), by Circulating Biomarkers 2024 & 2032
- Figure 51: Middle East and Africa Breast Biopsy Market Revenue (Million), by Country 2024 & 2032
- Figure 52: Middle East and Africa Breast Biopsy Market Volume (K Unit), by Country 2024 & 2032
- Figure 53: Middle East and Africa Breast Biopsy Market Revenue Share (%), by Country 2024 & 2032
- Figure 54: Middle East and Africa Breast Biopsy Market Volume Share (%), by Country 2024 & 2032
- Figure 55: South America Breast Biopsy Market Revenue (Million), by Circulating Biomarkers 2024 & 2032
- Figure 56: South America Breast Biopsy Market Volume (K Unit), by Circulating Biomarkers 2024 & 2032
- Figure 57: South America Breast Biopsy Market Revenue Share (%), by Circulating Biomarkers 2024 & 2032
- Figure 58: South America Breast Biopsy Market Volume Share (%), by Circulating Biomarkers 2024 & 2032
- Figure 59: South America Breast Biopsy Market Revenue (Million), by Country 2024 & 2032
- Figure 60: South America Breast Biopsy Market Volume (K Unit), by Country 2024 & 2032
- Figure 61: South America Breast Biopsy Market Revenue Share (%), by Country 2024 & 2032
- Figure 62: South America Breast Biopsy Market Volume Share (%), by Country 2024 & 2032
List of Tables
- Table 1: Global Breast Biopsy Market Revenue Million Forecast, by Region 2019 & 2032
- Table 2: Global Breast Biopsy Market Volume K Unit Forecast, by Region 2019 & 2032
- Table 3: Global Breast Biopsy Market Revenue Million Forecast, by Circulating Biomarkers 2019 & 2032
- Table 4: Global Breast Biopsy Market Volume K Unit Forecast, by Circulating Biomarkers 2019 & 2032
- Table 5: Global Breast Biopsy Market Revenue Million Forecast, by Region 2019 & 2032
- Table 6: Global Breast Biopsy Market Volume K Unit Forecast, by Region 2019 & 2032
- Table 7: Global Breast Biopsy Market Revenue Million Forecast, by Country 2019 & 2032
- Table 8: Global Breast Biopsy Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 9: United States Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 10: United States Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 11: Canada Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 12: Canada Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 13: Mexico Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 14: Mexico Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 15: Global Breast Biopsy Market Revenue Million Forecast, by Country 2019 & 2032
- Table 16: Global Breast Biopsy Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 17: Germany Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 18: Germany Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 19: United Kingdom Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 20: United Kingdom Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 21: France Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 22: France Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 23: Italy Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 24: Italy Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 25: Spain Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 26: Spain Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 27: Rest of Europe Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 28: Rest of Europe Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 29: Global Breast Biopsy Market Revenue Million Forecast, by Country 2019 & 2032
- Table 30: Global Breast Biopsy Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 31: China Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 32: China Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 33: Japan Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 34: Japan Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 35: India Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 36: India Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 37: Australia Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 38: Australia Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 39: South Korea Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 40: South Korea Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 41: Rest of Asia Pacific Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 42: Rest of Asia Pacific Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 43: Global Breast Biopsy Market Revenue Million Forecast, by Country 2019 & 2032
- Table 44: Global Breast Biopsy Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 45: GCC Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 46: GCC Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 47: South Africa Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 48: South Africa Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 49: Rest of Middle East and Africa Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 50: Rest of Middle East and Africa Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 51: Global Breast Biopsy Market Revenue Million Forecast, by Country 2019 & 2032
- Table 52: Global Breast Biopsy Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 53: Brazil Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 54: Brazil Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 55: Argentina Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 56: Argentina Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 57: Rest of South America Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 58: Rest of South America Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 59: Global Breast Biopsy Market Revenue Million Forecast, by Circulating Biomarkers 2019 & 2032
- Table 60: Global Breast Biopsy Market Volume K Unit Forecast, by Circulating Biomarkers 2019 & 2032
- Table 61: Global Breast Biopsy Market Revenue Million Forecast, by Country 2019 & 2032
- Table 62: Global Breast Biopsy Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 63: United States Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 64: United States Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 65: Canada Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 66: Canada Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 67: Mexico Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 68: Mexico Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 69: Global Breast Biopsy Market Revenue Million Forecast, by Circulating Biomarkers 2019 & 2032
- Table 70: Global Breast Biopsy Market Volume K Unit Forecast, by Circulating Biomarkers 2019 & 2032
- Table 71: Global Breast Biopsy Market Revenue Million Forecast, by Country 2019 & 2032
- Table 72: Global Breast Biopsy Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 73: Germany Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 74: Germany Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 75: United Kingdom Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 76: United Kingdom Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 77: France Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 78: France Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 79: Italy Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 80: Italy Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 81: Spain Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 82: Spain Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 83: Rest of Europe Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 84: Rest of Europe Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 85: Global Breast Biopsy Market Revenue Million Forecast, by Circulating Biomarkers 2019 & 2032
- Table 86: Global Breast Biopsy Market Volume K Unit Forecast, by Circulating Biomarkers 2019 & 2032
- Table 87: Global Breast Biopsy Market Revenue Million Forecast, by Country 2019 & 2032
- Table 88: Global Breast Biopsy Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 89: China Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 90: China Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 91: Japan Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 92: Japan Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 93: India Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 94: India Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 95: Australia Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 96: Australia Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 97: South Korea Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 98: South Korea Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 99: Rest of Asia Pacific Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 100: Rest of Asia Pacific Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 101: Global Breast Biopsy Market Revenue Million Forecast, by Circulating Biomarkers 2019 & 2032
- Table 102: Global Breast Biopsy Market Volume K Unit Forecast, by Circulating Biomarkers 2019 & 2032
- Table 103: Global Breast Biopsy Market Revenue Million Forecast, by Country 2019 & 2032
- Table 104: Global Breast Biopsy Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 105: GCC Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 106: GCC Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 107: South Africa Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 108: South Africa Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 109: Rest of Middle East and Africa Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 110: Rest of Middle East and Africa Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 111: Global Breast Biopsy Market Revenue Million Forecast, by Circulating Biomarkers 2019 & 2032
- Table 112: Global Breast Biopsy Market Volume K Unit Forecast, by Circulating Biomarkers 2019 & 2032
- Table 113: Global Breast Biopsy Market Revenue Million Forecast, by Country 2019 & 2032
- Table 114: Global Breast Biopsy Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 115: Brazil Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 116: Brazil Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 117: Argentina Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 118: Argentina Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 119: Rest of South America Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 120: Rest of South America Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Breast Biopsy Market?
The projected CAGR is approximately 21.23%.
2. Which companies are prominent players in the Breast Biopsy Market?
Key companies in the market include Fluxion Biosciences Inc, Janssen Diagnostics, Guardant Health Inc, Bio-Rad Laboratories Inc, Adaptive Biotechnologies, F Hoffmann-La Roche Ltd, Epic Sciences, PapGene, Qiagen, Pathway Genomics (OME Care), Exosome Diagnostics Inc, Illumina Inc, Myriad Genetics, Biocept Inc, Biodesix.
3. What are the main segments of the Breast Biopsy Market?
The market segments include Circulating Biomarkers.
4. Can you provide details about the market size?
The market size is estimated to be USD 0.41 Million as of 2022.
5. What are some drivers contributing to market growth?
Rising Prevalence of Breast Cancer; Increasing Demand for Better Minimally Invasive Therapies; Technological Advancements in the Early Stage Detection of Breast Cancer.
6. What are the notable trends driving market growth?
The Circulating Cell-free DNA (cfDNA) Segment is Expected to Hold a Major Market Share.
7. Are there any restraints impacting market growth?
Stringent Regulatory Issues; Poor Reimbursement Policies.
8. Can you provide examples of recent developments in the market?
N/A
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 5250, and USD 8750 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million and volume, measured in K Unit.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Breast Biopsy Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Breast Biopsy Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Breast Biopsy Market?
To stay informed about further developments, trends, and reports in the Breast Biopsy Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database



Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations

Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence